Activation of the complement system by injury increases inflammation by producing complement fragments C5a and C3a which are able to recruit and activate immune cells. Complement activation may contribute to pain after inflammation and injury. In this study, we examined whether C5a and C3a elicit nociception when injected into mouse hind paws in vivo, and whether C5a and C3a activate and/or sensitize mechanosensitive nociceptors when applied on peripheral terminals in vitro. We also examined the dorsal root ganglia (DRG) for C5a receptor (C5aR) 
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Introduction
The complement system is a group of more than 30 proteins, some of which can be serially activated and participate in a cascade that produces inflammation and participates in host defense. The complement system is activated in various injury states, e.g. rheumatoid arthritis [30] , multiple sclerosis [10], sepsis [42] and tissue injury by surgical trauma [11, 16, 18] .
Activation of the complement system enhances inflammation by producing split products such as complement fragments C5a and C3a that are potent proinflammatory peptides and act through G-protein coupled receptors (C5aR and C3aR, respectively) to exert their biological effects. C5a and C3a are able to enhance inflammation by recruiting and activating immune cells leading to the release of various algogenic mediators [12, 13, 43] . C5a and C3a may contribute to pain in pathologic states. For example, C5a receptor blockade decreased pain behaviors in inflammatory, neuropathic and postoperative pain models [5, 14, 39] indicating a pronociceptive role of C5a. However, there is little information on the effects of C5a and C3a on nociceptors. In this study, we tested whether the complement fragments C5a and C3a elicit pain when injected into the hind paw in vivo, and whether C5a and C3a activate and/or sensitize primary afferent nociceptors when applied on the peripheral terminals in vitro. We also examined the dorsal root ganglia (DRG) for C5aR mRNA using real time polymerase chain reaction (PCR) and effects of C5a and C3a on intracellular Ca 2+ concentration ([Ca 2+ ] i ) using Ca 2+ imaging.
Materials and methods

Animals
Male C57BL/6J mice (20-30 g and 6-12 weeks of age, Jackson Labs) that were housed in groups of 4-5, with food and water available ad libitum under a 12-h light/dark cycle, were used in this study. Experimental protocols were approved by The Animal Care and Use Committee at The University of Iowa and the Institutional Animal Care and Use Committee, VAPAHCS.
